Cancer of the prostate. Methods of initial diagnosis
Iturrigui-Pagán, J.R.
Boletin de la Asociacion Medica de Puerto Rico 83(5): 196-198
1991
ISSN/ISBN: 0004-4849 PMID: 1930473 Document Number: 700278
We herein describe teh diagnostic methods available for the screening of Carcinoma of the Prostate. As recommended by the NCI. Rectal Digital Exam (RDE) and Prostatic Specific Antigens (PSA) are the usual screening methods to be use. Depending on their results, we proceed with Transrectal Prostatic Ultrasound with or without biopsy.
Document emailed within 1 workday
Related Documents
Patel, P.; Nayak, J.G.; Biljetina, Z.; Donnelly, B.; Trpkov, K. 2015: Prostate cancer after initial high-grade prostatic intraepithelial neoplasia and benign prostate biopsy Canadian Journal of Urology 22(6): 8056-8062Miyamoto, S.; Jimbo, H.; Totsuka, Y.; Mashimo, T.; Umeyama, T.; Uehara, H.; Shinozaki, T. 1995: Change in serum prostate specific antigen values in men who had no evidence of prostate cancer on initial biopsy Hinyokika Kiyo. Acta Urologica Japonica 41(10): 767-770
Romppanen, J.; Haapalainen, T.; Punnonen, K.; Penttilä, I. 2002: Serum sialic acid and prostate-specific antigen in differential diagnosis of benign prostate hyperplasia and prostate cancer Anticancer Research 22(1a): 415-420
Walton-Diaz, A.; Rais-Bahrami, S. 2018: When to Order an MRi in the Initial Evaluation and Management of Prostate Cancer Oncology 32(10): 501-504
Squillaci, E.; Manenti, G.; Mancino, S.; Carlani, M.; Di Roma, M.; Colangelo, V.; Simonetti, G. 2005: MR spectroscopy of prostate cancer. Initial clinical experience Journal of Experimental and Clinical Cancer Research: Cr 24(4): 523-530
Topuzov, M.E. 2007: Role of density of prostate-specific antigen transitory zone in early diagnosis of prostate cancer Voprosy Onkologii 53(3): 295-297
De la Taille, A.; Houlgatte, A.; Houdelette, P.; Berlizot, P.; Ramirez, J.; Ricordel, I. 1997: Value of free/total prostate specific antigen in the early diagnosis of prostate cancer (study of 105 patients) Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(2): 240-245
Jung, P.; Wolff, J.M.; Mattelaer, P.; Jakse, G. 1996: Prostate specific antigen in the diagnosis and staging of prostate cancer Acta Urologica Belgica 64(3): 1-6
Jaukovic, L.; Adjinovic, B.; Cerovic, S.; Joksimovic, M.; Soldatovic, Z. 2011: Is bone scintigraphy necessary in initial staging of prostate cancer patients? Hellenic Journal of Nuclear Medicine 14(2): 126-130
Rigaud, J.ér.ôm.; Bouchot, O. 2003: Prostate specific antigen and diagnosis of prostate cancer La Revue du Praticien 53(20): 2229-2236
Qu, H.-W.; Liu, H.; Cui, Z.-L.; Jin, X.-B.; Zhao, Y.; Wang, M.-W.; Song, W.; Zhang, X.-J. 2016: Focusing on MRI-suspected lesions in targeted transrectal prostate biopsy guided by MRI-TRUS fusion imaging for the diagnosis of prostate cancer Zhonghua Nan Ke Xue 22(9): 782-786
Solé Balcells, F.J. 1989: Early diagnosis of cancer of the prostate. Value of systemic screening and of diagnosis in incidental cancer (stage A) Archivos Espanoles de Urologia 42(Suppl 2): 131-138
Shain, S.A.; Boesel, R.W.; Kalter, S.S.; Heberling, R.L. 1981: A x C rat prostate adenocarcinoma: initial characterization of testosterone regulation of hormone receptors of cultured cancer cells and derived tumors Journal of the National Cancer Institute 66(3): 565-574
Leewansangtong, S.; Vorrakitkatorn, P.; Amornvesukit, T.; Taweemonkongsap, T.; Nualyong, C.; Sujijantararat, P. 2010: Laparo-endoscopic single site (LESS) robotic radical prostatectomy in an Asian man with prostate cancer: an initial case report Journal of the Medical Association of Thailand 93(3): 383-387
Yang, W.; Liu, S.; Hu, C.; Xie, K.; Wei, X.; Zeng, W.; Tang, P. 2019: Distributions and characteristics of initial PSA and PSA velocity in Chinese men aged 50 years and younger without prostate cancer: a multi-center study Journal of BUON: Official Journal of the Balkan Union of Oncology 24(2): 832-837
Zissimopoulos, A.; Stellos, K.; Matthaios, D.; Petrakis, G.; Parmenopoulou, V.; Babatsikou, F.; Matthaiou, E.; Theodosiadou, E.; Hountis, P.; Koutis, C. 2009: Type i collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy Journal of Buon: Official Journal of the Balkan Union of Oncology 14(3): 463-472
Kaprin, A.D.; Khmelevskiĭ, E.V.; Fadeev, A.V. 2008: Current methods of radical treatment for localized prostate cancer Voprosy Onkologii 54(1): 108-112
Schalken, J.A. 1991: Molecular methods for predicting the metastatic potential of prostate cancer Cancer Surveys 11: 43-54
Murray, N.P.; Aedo, S.óc.; Reyes, E.; Fuentealba, C.; Jacob, O. 2019: Primary circulating prostate cells, age and prostatic volumen predict the presence of prostate cancer in men with indication of a second prostate biopsy Archivos Espanoles de Urologia 72(1): 16-24
Romas, N.A.; Veenema, R.J.; Hsu, K.C.; Tomashefsky, P.; Lattimer, J.K.; Tannenbaum, M. 1979: Bone marrow acid phosphatase in prostate cancer: an assessment by immunoassay and biochemical methods Transactions of the American Association of Genito-Urinary Surgeons 71: 26-30